Dr. Evan David Muse, MD, PhD

Dr. Muse practices at Scripps Clinic la Jolla ASC in La Jolla, California.

Dr. Muse's NPI, 1285883074, was assigned on September 16, 2008. Dr. Muse graduated from Albert Einstein College of Medicine in 2008. Dr. Muse holds California license A122629.

Dr. Muse's primary practice is Scripps Clinic la Jolla ASC, at 9898 Genesee Avenue, La Jolla, CA 92037. The practice phone is (414) 975-3807.

Dr. Muse's primary practice is Scripps Clinic la Jolla ASC in La Jolla, California. Dr. Muse is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Muse to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muse practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Muse's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Muse is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Muse's licenses on file in 2 states: California and Maryland.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension, circulation problems and congestive heart failure among the conditions Dr. Muse treats.

CMS data shows 2,916 Medicare services from Dr. Muse across 12 procedure codes in 2024, for 1,673 Medicare patients. Medicare paid $125,994 for them.

CMS counts 1,673 Medicare patients who saw Dr. Muse in 2024. The largest group is 75 to 84, with 730 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Muse's median patient age at 61, with 49% women.

In 2024, Dr. Muse wrote 3,056 Medicare Part D claims for 443 patients. 80% of them were for generic drugs. CMS names the drug for 2,916 of them, across 34 drugs with 11 or more claims each, at $776,047 in total drug cost. In 2023, CMS named 2,724 claims across 30 drugs.

Dr. Muse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Muse as offering telehealth.

Dmand AI links 63 papers to Dr. Muse, published from 2006 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Artificial Intelligence, Atrial Fibrillation and Electrocardiography. Dr. Muse has published most often in Lancet. Dr. Muse's most frequent co-authors are Eric J. Topol, MD, Steven Rudolf Steinhubl, MD and Paddy Barrett, MB, BCH, BAO.

Dmand AI links Dr. Muse to 1 clinical trial.

CMS Open Payments shows 30 general payments to Dr. Muse from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Abbott Laboratories paid the most, $1,717.

Dr. Muse graduated from Albert Einstein College of Medicine in 2008. Dr. Muse is a member of ACC and AHA.

Dr. Muse is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.